Dimerix Limited (ASX: DXB)
Australia
· Delayed Price · Currency is AUD 0.345
+0.020 (6.15%)
Nov 22, 2024, 4:10 PM AEST
Dimerix Revenue
In the fiscal year ending June 30, 2024, Dimerix had annual revenue of 583.48K AUD with 1,486.10% growth. Dimerix had revenue of 450.42K in the half year ending June 30, 2024, a decrease of -93.03%.
Revenue
583.48K
Revenue Growth
+1,486.10%
P/S Ratio
267.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
192.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 583.48K | 546.69K | 1,486.10% |
| Jun 30, 2023 | 36.79K | -6.43M | -99.43% |
| Jun 30, 2022 | 6.46M | 2.02M | 45.58% |
| Jun 30, 2021 | 4.44M | 2.10M | 89.65% |
| Jun 30, 2020 | 2.34M | 893.56K | 61.74% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.60B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Ramsay Health Care Limited | 16.66B |
| Telix Pharmaceuticals Limited | 645.68M |